The Health Sciences Institute is intended to provide cutting-edge health information.
Nothing on this site should be interpreted as personal medical advice. Always consult with your doctor before changing anything related to your healthcare.

Choose your poison

The current debate over the safety of ephedra is no longer a debate – it’s turned into the sort of emotional, high-pitched squabbling that makes you want to blast a whistle and ask everyone to calm down, take a deep breath, stand back, and look at the realities behind the myths.

Because when you expose the myths behind this debate, it becomes almost no debate at all.

The infamous “100” 

Believe me, what you’re about to read, you won’t find in your local newspaper, or on network TV. They’re so busy putting up packaged sound bites from the medical mainstream (with all the familiar acronyms: FDA, HHS, AMA) that they don’t have time to outline the finer points that contain the truth of the ephedra debate.

MYTH: More than 100 deaths have been attributed to ephedra usage.

FACT: The statistics on ephedra-related deaths don’t hold up.

The FDA received more than 800 adverse event reports concerning ephedra between 1993 and 1997. Included in the reports: a man who was taking ephedra died of a gunshot wound; a woman who had been taking ephedra died in a car accident; a man who had been taking ephedra died of environmental hyperthermia; and so on. To say the least, it’s quite a stretch to blame these untimely deaths on the completely incidental fact that the victims were using ephedra. I imagine all of those people were wearing shoes too, but I doubt anyone blamed shoes for their deaths.

In the current issue of HSI, Panelist Jon Barron’s Baseline of Health Newsletter, writes, “The case against ephedra is based on statistical nonsense.” Jon points out that in the studies examining groups of subjects who used ephedra products against groups of subjects who did not, there was no statistical difference in the rate of strokes or heart attacks.

Cascade of events 

MYTH: Ephedra killed Baltimore Orioles pitcher Steve Bechler.

FACT: Several different factors led to Bechler’s death. Ephedra was not one of them.

A bottle of Xenadrine RFA-1, a weight-loss supplement containing ephedrine (NOT ephedra, but a boosted component of the herb ephedra) was found in Bechler’s locker. A teammate reported that Bechler had taken three capsules of Xenadrine on the morning of his death (not yet confirmed by the medical examiner’s toxicology report which has yet to be completed). According to instructions on the Xenadrine label, three capsules are to be taken throughout the day, not all at once.

One week after his death, three doctors at the Baylor University Center for Exercise, Nutrition and Preventive Health Research released a special report listing the dangerous factors that contributed to Steve Bechler’s death:

  • A prior history of heart illness
  • A family history of death due to heatstroke
  • A history of liver problems and high blood pressure
  • Bechler had reported to spring training camp several pounds overweight (and was highly motivated to lose the weight in order to win a spot in the Orioles pitching rotation)
  • Bechler was wearing several layers of clothing during workouts in an apparent attempt to help his weight-loss regimen
  • Bechler may have not yet been acclimatized to the heat and humidity of South Florida (spring training had just begun the week he died)
  • Bechler had eaten no solid food for as much as two days before his death
  • When Bechler collapsed on the field, his core temperature was 106 degrees
Dr. Joshua Perper, the Broward County (Fla.) Medical Examiner, stated that the Xenadrine label clearly states that those with heart problems, hypertension or liver problems should not take the supplement. So if Steve Bechler had followed the manufacturers guidelines, he would never have taken ephedrine at all.

If for some reason I choose to drink gasoline and I were to die from it, would the FDA ban the sale of gasoline? And should my family sue Exxon? No. Because I was using the product in a way it was not intended to be used. And that’s exactly what happened here – and in the majority of other cases where ephedrine is seen as the “killer.” Ephedrine is not intended to be used in these doses by people with certain health conditions.

Looking the other way 

MYTH: The FDA bans food or drug products that are dangerous.

FACT: The arbitrary nature of FDA bans defies logic.

Aspartame is perhaps the most notoriously harmful food additive. Better known by its brand names – Equal and Nutra-sweet – aspartame has been shown to either mimic or worsen diseases such as Parkinson’s, multiple sclerosis, Alzheimer’s, arthritis, lupus, fibromyalgia, and depression. In short – it’s FDA approved poison.

The FDA maintains an Adverse Reaction Monitoring System (ARMS) to track complaints about the unpleasant side effects of drugs, supplements and food additives. Reports of health problems resulting from an intake of aspartame make up approximately 75 percent of the total complaints received. In 1994 the Department of Health and Human Services (HHS) released a list of 61 reported adverse reactions to aspartame, including: chest pains, asthma, arthritis, migraine headaches, insomnia, seizures, tremors, vertigo, and weight gain.

So has either the FDA or HHS called for a ban of aspartame? No. Has either of the agencies even called for a warning label? No. In fact, the FDA has resisted efforts to establish a warning label for aspartame, stating (completely contrary to all the evidence) that the complaints against the sweetener aren’t sufficient enough to warrant such a label!

And have you heard the media calling for us to immediately remove every (heavily advertised) diet soft drink from our grocery store shelves to protect the public from the awful risk? After all, we’re supposed to drink that “just for the taste of it.” So to quote HHS Secretary Tommy Thompson, “Why would anybody take the risk?”

Witch hunt mentality

The current ephedra situation reminds me of a similar controversy involving l-tryptophan, a dietary supplement, used as a natural alternative to pharmaceutical sleeping medications. In 1989 there was a sudden rash of serious allergic reactions to l-tryptophan that resulted in 38 deaths. The problem was tracked down to a manufacturing short cut taken by one Japanese producer that had introduced a contaminant they didn’t know about. L-tryptophan had been used for years without difficulty. But all it took was one bad batch. The FDA banned supplements of l-tryptophan in 1990.

When herbal formulations or dietary supplements begin to be perceived as dangerous, the medical mainstream moves quickly to demonize them – and by association, they demonize the supplement industry. This time, the demonizing process is gaining momentum daily. Congressmen and other government representatives see what appears to be a no-brainer issue and rush to publicly condemn the killer ephedra, many of them apparently unaware that ephedra is a far cry from ephedrine. Even the liberal lobby organization Public Citizen has threatened to sue the FDA to force a ban on ephedra.

It’s quite amazing to see Public Citizen demanding that the government intervene to block everyone’s access to an effective and useful herb (that has probably saved many more lives than it is accused of ending) in order to protect a few people who choose not to use it properly.

Meanwhile, no one seems to notice that this process is steadily legislating ourselves away from the freedom to make our own healthcare choices. Let your representatives in Congress know how you feel about this issue by sending them an e-mail. You can easily find e-mail addresses for congressmen and other government officials at a web site called Congress.org. If you prefer to write the old-fashioned way, you can find the appropriate mailing addresses at the same site.

And I hope you’ll share this information with your friends and family too. Let them know that the information they’ve been hearing about ephedra in the mainstream press is not only short on reality, it’s also a threat to our right to choose.

Share the HSI e-Alert with a friend

 

To Your Good Health,

Jenny Thompson
Health Sciences Institute

Sources:
“FDA Rolling Out Ephedra Warning Labels” Lauran Neergaard, Associated Press, 3/2/03
“Interesting Times” Jon Barron & Kristen Barron, Baseline of Health Newsletter, 3/3/03, jonbarron.com
“The History of the FDA’s Opposition to Ephedra” Ephedra Education Council, ephedrafacts.com
“The Alleged Role of Ephedra in the Death of a Professional Baseball Player” Kreider, Greenwood & Greenwood, Exercise & Sport Nutrition Lab, Center for Exercise, Nutrition and Preventive Health Research, Baylor University, 2/21/03
“Reported Aspartame Toxicity Effects” Holistic Healing Web Page, holisticmed.com
“AspartameThe BAD News!” Mark Gold, doorway.com

 

 

 

 

 

 

Get a free copy of 5 Household Items that Cause Cancer

By texting HSI to 844-539-1128, you are providing your electronic signature expressly consenting to be called and texted (including by prerecorded messages, using an autodialer, and/or automated means) with alerts, stories, reports, and marketing communications from Institute of Health Sciences, LLC. and its authorized representatives at the phone number you provide, including landlines and wireless numbers, even if the phone number is on a corporate, state or national Do Not Call list. You also consent and unconditionally agree to our Privacy Policy and Terms of Use, including the arbitration provision and class action waiver contained therein. Msg&data rates may apply. 15 Msgs/Month. You are not required to agree to this as a condition of making a purchase.

Terms & Conditions

The following Terms and Conditions apply to your use of the website located at hsionline.com (the “website”) and any text messages that you send to or receive from the Institute of Health Sciences, L.L.C. These Terms and Conditions constitute a binding agreement (“Agreement”) between you (“you”) Institute of Health Sciences, L.L.C (“we”, “us”, etc.)  Please read these terms carefully. 

By providing your telephone number to us, texting us a short code listed on the website, or otherwise indicate your agreement to these Terms and Conditions, you are agreeing to the mandatory arbitration provision and class action waiver below. 

ARBITRATION IS MANDATORY AND THE EXCLUSIVE REMEDY FOR ANY AND ALL DISPUTES RELATED TO THIS WEBSITE, THIS AGREEMENT, AND ANY TELEPHONE CALLS, EMAILS, OR TEXT MESSAGES THAT YOU RECEIVE FROM OR ON BEHALF OF US, UNLESS SPECIFIED BELOW OR UNLESS YOU OPT-OUT.

Text Messaging and Telemarketing Terms and Conditions

When you provide your telephone number on this website or send a text message to us with or from a short-code, you agree to receive alerts and communications, and marketing messages including those sent via automated telephone dialing system, text messages, SMS, MMS, and picture messages from Institute of Health Sciences, L.L.C at the phone number you provide on this website or the phone number from which you text the short code, including on landlines and wireless numbers, even if the phone number is on a corporate, state or national Do Not Call list. You also agree to the mandatory arbitration provision and class action waiver below. Your consent is not required to purchase goods or services. Message & data rates may apply.

You may opt-out at any time by texting the word STOP to the telephone number from which you receive the text messages.  Call 1-888-213-0764 to learn more.  By providing your telephone number, you agree to notify us of any changes to your telephone number and update your account us to reflect this change. Your carrier may charge you for text messages and telephone calls that you receive, or may prohibit or restrict certain mobile features, and certain mobile features may be incompatible with your carrier or mobile device. Contact your carrier with questions regarding these issues.

Dispute Resolution by Binding Arbitration and Class Action Waiver

Any dispute relating in any way to telephone calls, emails, or text messages that you receive from or on behalf of Institute of Health Sciences, L.L.C this website, or this Agreement (collectively “Disputes”) shall be submitted to confidential arbitration and shall be governed exclusively by the laws of the State of Maryland, excluding its conflict of law provisions.  For the avoidance of doubt, all claims arising under the Telephone Consumer Protection Act and state telemarketing laws shall be considered “Disputes” that are subject to resolution by binding individual, confidential arbitration.

If a Dispute arises under this Agreement, you agree to first contact us at 1-888-213-0764 or help@hsionline.com. Before formally submitting a Dispute to arbitration, you and we may choose to informally resolve the Dispute.  If any Dispute cannot be resolved informally, you agree that any and all Disputes, including the validity of this arbitration clause and class action waiver, shall be submitted to final and binding arbitration before a single arbitrator of the American Arbitration Association (“AAA”) in a location convenient to you or telephonically. Either you or we may commence the arbitration process by submitting a written demand for arbitration with the AAA, and providing a copy to the other party.  The arbitration will be conducted in accordance with the provisions of the AAA’s Commercial Dispute Resolutions Procedures, Supplementary Procedures for Consumer-Related Disputes, in effect at the time of submission of the demand for arbitration.  Except as may be required by law as determined by the arbitrator, no party or arbitrator may disclose the existence, content or results of any arbitration hereunder without the prior written consent of both parties. Institute of Health Sciences, L.L.C will pay all of the filing costs.  Without limiting the foregoing, YOU EXPRESSLY AGREE TO SUBMIT TO ARBITRATION ALL DISPUTES RELATING TO ANY TEXT MESSAGES OR TELEPHONE CALLS YOU RECEIVE FROM OR ON BEHALF OF US OR ANY ENTITY WITH WHOM WE MAY SHARE YOUR TELEPHONE NUMBER.  Further, we both agree that all entities with whom we share your telephone numbers shall be third party beneficiaries of this Agreement to Arbitrate Disputes, and that those entities have the same rights as Institute of Health Sciences, L.L.C to enforce this arbitration provision.

Notwithstanding the foregoing, the following shall not be subject to arbitration and may be adjudicated only in the state and federal courts of Maryland: (i) any dispute, controversy, or claim relating to or contesting the validity of our or one of our family company’s intellectual property rights and proprietary rights, including without limitation, patents, trademarks, service marks, copyrights, or trade secrets; (ii) an action by us for temporary or preliminary injunctive relief, whether prohibitive or mandatory, or other provisional relief; (iii) any legal action by us against a non-consumer; or (iv) interactions with governmental and regulatory authorities.  You expressly agree to refrain from bringing or joining any claims in any representative or class-wide capacity, including but not limited to bringing or joining any claims in any class action or any class-wide arbitration.

The arbitrator’s award shall be binding and may be entered as a judgment in any court of competent jurisdiction. To the fullest extent permitted by applicable law, no arbitration under this Agreement may be joined to an arbitration involving any other party subject to this Agreement, whether through a class action, private attorney general proceeding, class arbitration proceedings or otherwise.

YOU UNDERSTAND THAT YOU WOULD HAVE HAD A RIGHT TO LITIGATE IN A COURT, TO HAVE A JUDGE OR JURY DECIDE YOUR CASE AND TO BE PARTY TO A CLASS OR REPRESENTATIVE ACTION.  HOWEVER, YOU UNDERSTAND AND AGREE TO HAVE ANY CLAIMS DECIDED INDIVIDUALLY AND ONLY THROUGH ARBITRATION.  You shall have thirty (30) days from the earliest of the date that you visit the website, the date you submit information to us through the website, or the date that you send a text message to us, to opt out of this arbitration agreement, by contacting us by email at help@hsionline.com or by mail Health Sciences Institute, PO Box 913, Frederick, MD 21705-0913. If you do not opt out by the earliest of the date that you visit the website, the date you submit information to us through the website, or the date that you send a text message to us, then you are not eligible to opt out of this arbitration agreement.

Electronic Signatures

All information communicated on the website is considered an electronic communication.  When you communicate with us through or on the website, by text message or telephone, or via other forms of electronic media, such as e-mail, you are communicating with us electronically.  You agree that we may communicate electronically with you and that such communications, as well as notices, disclosures, agreements, and other communications that we provide to you electronically, are equivalent to communications in writing and shall have the same force and effect as if they were in writing and signed by the party sending the communication.

You further acknowledge and agree that by clicking on a button labeled “ORDER NOW”, “SUBMIT”, “I ACCEPT”, “I AGREE”, “YES”, by texting a short code to us in response to a request on this website, or by clicking or similar links or buttons, you are submitting a legally binding electronic signature and are entering into a legally binding contract.  You acknowledge that your electronic submissions constitute your agreement and intent to be bound by this Agreement.  Pursuant to any applicable statutes, regulations, rules, ordinances or other laws, including without limitation the United States Electronic Signatures in Global and National Commerce Act, P.L. 106-229 (the “E-Sign Act”) or other similar statutes, YOU HEREBY AGREE TO THE USE OF ELECTRONIC SIGNATURES, CONTRACTS, ORDERS AND OTHER RECORDS AND TO ELECTRONIC DELIVERY OF NOTICES, POLICIES AND RECORDS OF TRANSACTIONS INITIATED OR COMPLETED THROUGH THE WEBSITE.  Furthermore, you hereby waive any rights or requirements under any statutes, regulations, rules, ordinances or other laws in any jurisdiction which require an original signature, delivery or retention of non-electronic records, or to payments or the granting of credits by other than electronic means You may receive a physical paper copy of this contract by contacting us at help@hsionline.com.

Privacy Policy

Please read our Privacy Policy, which is incorporated herein by reference.  In the event of any conflict between these Terms and Conditions and the Privacy Policy, these Terms shall control.

Contact Us

You may contact us by telephone at 1-888-213-0764 or by email at help@hsionline.com.